Navidea Biopharmaceuticals, Inc. Welcomes Jill Bieker Stefanelli, Ph.D. to Board of Directors; Alexander L. Cappello Steps Down

In line with the Company’s Fix, Fund, Propel approach, Jill Bieker Stefanelli, Ph.D. joins Board, adding precision medicine and product development depth in support of stated strategy to... | June 1, 2023

Related Keywords

United States ,Colorado ,Kansas ,American ,Alexanderl Cappello ,Johnk Scott Jr ,Navidea Manocept ,Jason Myers ,Jill Bieker Stefanelli ,Invitae Archer ,Clinical Commercial Development Lead At Life Technologies ,Sandia National Laboratories ,Company Board Of Directors ,Animal Sciences Industry ,Precision Medicine Companies ,Company Board ,Securities Exchange ,Department Of Diagnostic Medicine Pathobiology ,Navidea Biopharmaceuticals Inc ,Navidea Biopharmaceuticals ,Precision Medicine Leader ,Bieker Stefanelli ,Scientific Advisor ,Independent Board ,Board Member ,Chief Business Officer ,Senior Vice President ,Clinical Commercial Development Lead ,Life Technologies ,Genomics Specialist ,Roche Diagnostics ,Sandia National ,Animal Sciences ,Molecular Medicine ,Diagnostic Pathology ,Veterinary School ,Kansas State ,Vice Chair ,Securities Act ,Securities Exchange Act ,Annual Report ,Nc Stock Exchange ,News ,Information ,Press Release ,N ,Line ,Ith ,The ,Propel ,Hill ,Sieker ,Coins ,Redding ,Precision ,Medicine ,End ,Product ,Development ,Depth ,Support ,F ,Tated ,Trategy Navb Us63937x2027 ,